Abigail R Fabiano
Overview
Explore the profile of Abigail R Fabiano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
5
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fabiano A, Newman M, Dombroski J, Rowland S, Knoblauch S, Kusunose J, et al.
Adv Sci (Weinh)
. 2025 Feb;
:e2412995.
PMID: 39976192
Non-surgical and safe prostate cancer (PCa) therapies are in demand. Soluble tumor necrosis factor (TNF-α) related apoptosis inducing ligand (TRAIL), a cancer-specific drug, shows preclinical efficacy but has a short...
2.
Fabiano A, Robbins S, Knoblauch S, Rowland S, Dombroski J, King M
Commun Biol
. 2024 Jun;
7(1):674.
PMID: 38824207
Studying cellular mechanoresponses during cancer metastasis is limited by sample variation or complex protocols that current techniques require. Metastasis is governed by mechanotransduction, whereby cells translate external stimuli, such as...
3.
Dombroski J, Fabiano A, Knoblauch S, Rowland S, Gibson-Corley K, King M
J Immunol Methods
. 2023 Dec;
524:113601.
PMID: 38092224
A tumor nano-lysate "TNL" vaccine comprised of sonicated 4T1 cells was developed, characterized and implemented for the prevention of triple-negative breast cancer. This study aimed to gain a better understanding...
4.
Dombroski J, Rowland S, Fabiano A, Knoblauch S, Hope J, King M
Immunobiology
. 2023 Sep;
228(6):152744.
PMID: 37729773
Ex vivo activation of dendritic cells (DCs) has been widely explored for targeted therapies, although these treatments remain expensive. Reducing treatment costs while enhancing cell activation could help to make...